General Information of Drug (ID: DM4IJXW)

Drug Name
2-MOE phosphorothioate gapmers Drug Info
Synonyms Oligo445236; Oligo445238
Indication
Disease Entry ICD 11 Status REF
Myotonic dystrophy 8C71.0 Investigative [1]
Cross-matching ID
TTD Drug ID
DM4IJXW

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-DMPK DMH32LC Myotonic dystrophy 8C71.0 Phase 1/2 [2]
RKI-1447 DMGTAWC Discovery agent N.A. Investigative [3]
PRO-135 DMA2SBL Myotonic dystrophy 8C71.0 Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DMPK messenger RNA (DMPK mRNA) TTZQTY2 DMPK_HUMAN Not Available [1]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1505).
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.
3 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2). Medchemcomm. 2012 Jun 1;3(6):699-709.